ME
IBB icon

McIlrath & Eck’s iShares Biotechnology ETF IBB Stock Holding History

McIlrath & Eck’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30
Closed -$3.97K – 969
2024
Q4 		$3.97K Buy
+30
New +$4.22K ﹤0.01% 792
2020
Q1 		– Sell
-512
Closed -$62K – 683
2019
Q4 		$62K Buy
+512
New +$57.1K 0.03% 123
2019
Q3 		– Sell
-33
Closed -$4K – 638
2019
Q2 		$4K Hold
33
– – ﹤0.01% 489
2019
Q1 		$4K Buy
+33
New +$3.62K ﹤0.01% 489

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

McIlrath & Eck's IBB Position: Q1 2025 in Review

McIlrath & Eck sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 30 shares — an estimated $3.97K sold.

McIlrath & Eck first reported a position in IBB in Q1 2019 and held it in 4 quarters. The position peaked at $62K in Q4 2019. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • McIlrath & Eck reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • McIlrath & Eck sold 30 iShares Biotechnology ETF shares in Q1 2025, an estimated $3.97K.
  • McIlrath & Eck first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 4 quarters.
  • McIlrath & Eck's iShares Biotechnology ETF position peaked at $62K in Q4 2019.
  • 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on McIlrath & Eck's 13F filing for Q1 2025, filed 16 May 2025.